Sangamo Therapeutics, Inc financial data

Symbol
SGMO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
501 Canal Blvd., Richmond, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
SANGAMO BIOSCIENCES INC (to 1/6/2017)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 154 % -50%
Debt-to-equity 146 % +166%
Return On Equity -40.4 % +10.5%
Return On Assets -108 % -67.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 209M shares +17.6%
Common Stock, Shares, Outstanding 178M shares +6.8%
Entity Public Float 229M USD -63.8%
Common Stock, Value, Issued 2.09M USD +17.7%
Weighted Average Number of Shares Outstanding, Basic 208M shares +17.6%
Weighted Average Number of Shares Outstanding, Diluted 214M shares +21%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 52.3M USD -74%
Research and Development Expense 139M USD -44.5%
General and Administrative Expense 48M USD -25.7%
Operating Income (Loss) -140M USD +47.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -135M USD +46.9%
Income Tax Expense (Benefit) -12K USD +99.7%
Net Income (Loss) Attributable to Parent -135M USD +46%
Earnings Per Share, Basic -0.76 USD/shares +47.2%
Earnings Per Share, Diluted -0.76 USD/shares +47.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 39.2M USD -30.6%
Cash, Cash Equivalents, and Short-term Investments 81M USD -73.7%
Accounts Receivable, after Allowance for Credit Loss, Current 10.5M USD +814%
Assets, Current 58.1M USD -60.6%
Property, Plant and Equipment, Net 19.1M USD -32.7%
Operating Lease, Right-of-Use Asset 17.8M USD -34.7%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Goodwill 0 USD -100%
Other Assets, Noncurrent 16.6M USD -2.33%
Assets 111M USD -49.4%
Accounts Payable, Current 19.8M USD +28%
Accrued Liabilities, Current 11.6M USD -18.3%
Contract with Customer, Liability, Current 774K USD -47.9%
Liabilities, Current 43.2M USD -11%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 27.7M USD -20.7%
Other Liabilities, Noncurrent 1.24M USD -5.84%
Liabilities 72.1M USD -14.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.22M USD +35.8%
Retained Earnings (Accumulated Deficit) -1.48B USD -10%
Stockholders' Equity Attributable to Parent 39.1M USD -71%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 82.9M USD -71.9%
Liabilities and Equity 111M USD -49.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -48.7M USD +26.6%
Net Cash Provided by (Used in) Financing Activities 22.1M USD +176%
Net Cash Provided by (Used in) Investing Activities 35.8M USD +0.31%
Common Stock, Shares Authorized 960M shares
Common Stock, Shares, Issued 178M shares +6.8%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.63M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 40.7M USD -29.8%
Deferred Tax Assets, Valuation Allowance 351M USD +16.4%
Deferred Tax Assets, Gross 357M USD +9.97%
Operating Lease, Liability 38.1M USD -11.6%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -132M USD +44.1%
Lessee, Operating Lease, Liability, to be Paid 45.2M USD -13.9%
Property, Plant and Equipment, Gross 77.9M USD -22.1%
Operating Lease, Liability, Current 4.59M USD +11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.56M USD +3.29%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.83M USD -0.07%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.88M USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.54M USD -0.19%
Deferred Tax Assets, Operating Loss Carryforwards 197M USD +13%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 18.3M USD +0.78%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.49M USD -0.64%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.41M USD -59.7%
Deferred Tax Assets, Net of Valuation Allowance 5.76M USD -74.9%
Share-based Payment Arrangement, Expense 15.2M USD -48.5%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%